🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523577-42-00
Authorised Phase I

Open label study to investigate patch adhesion of an Esflurbiprofen-containing patch in healthy volunteers

2025-523577-42-00 · tracked via the Priya Life Science EU tracker
Sponsor
Teikoku Seiyaku Co. Ltd.
Sponsor type
Pharmaceutical company
Therapeutic area
Musculoskeletal Diseases
Decision date
13/11/2025
Enrollment target
90
Sites
Germany

Condition studied

Patch adhesion trial with healthy subjects, therapeutical indication not studied

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523577-42-00 on CTIS ↗ ← All trials in the EU